Defined Research To Present Results From CBD Clinical Trial For Insomnia At Sleep 2023 Medical Conference
Defined Research, Inc., a science-based wellness company announced the results of its clinical trial for Defined Sleep, a proprietary oral cannabidiol (CBD)-based formula. According to Harvard Medical School, the average U.S. worker loses 11.3 days, or $2,280, a national cost to the workforce of $63.2 billion due to insomnia.
